Press release
Intestine Cancer Therapeutics Market Landscape 2025: Forecast Data and Growth Strategy Insights
Intestine Cancer Therapeutics
What Is the Expected CAGR for the Intestine Cancer Therapeutics Market Through 2025?
The market for intestinal cancer therapeutics has seen a significant expansion in its size over the recent few years. The market is projected to escalate from a size of $14 billion in 2024 to reach $15.26 billion in 2025, equating to a compound annual growth rate (CAGR) of 9.0%. The expansion observed in the historic period was fueled by improvements in medical research, a rise in cancer occurrences, advances in chemotherapy and radiation therapy, initiatives for early detection and screening, and the discovery of new genetic and biomarker targets.
What's the Projected Size of the Global Intestine Cancer Therapeutics Market by 2029?
The market size for therapies associated with intestine cancer is projected to experience robust growth in the upcoming years, reaching $21.15 billion by 2029 with a compound annual growth rate of 8.5%. The key drivers propelling this growth rate during the forecast period include advancements in immunotherapy, the emergence of precision and personalized therapies, the implementation of AI technology, and a patient-centric focus. Future trends encompass liquid biopsy technologies, research into precision and biomarker medicine, the application of combination therapies, patient-driven care and supportive therapies, and the increasing preference for minimally invasive surgical practices.
View the full report here:
https://www.thebusinessresearchcompany.com/report/intestine-cancer-therapeutics-global-market-report
Top Growth Drivers in the Intestine Cancer Therapeutics Industry: What's Accelerating the Market?
The projected rise in hereditary colorectal cancer syndromes is anticipated to boost the intestine cancer therapeutics market's expansion. These syndromes are a collection of genetic disorders that heighten the likelihood of a person contracting colorectal cancer (cancer of the colon or rectum*). In the context of intestinal cancer therapeutics, these syndromes provide valuable insights into specific genetic mutations that dramatically enhance the risk of colorectal cancer development. As per the World Health Organization, a Switzerland-based intergovernmental entity, in July 2023, the incidence of hereditary colorectal cancer is predicted to experience substantial growth, recording an estimated 3.2 million new instances and 1.6 million deaths annually by 2040. These figures denote a 63% rise in new cases and a 73% surge in death rate from the present numbers. Hence, the escalating incidence of hereditary colorectal cancer syndromes is fueling the expansion of the intestine cancer therapeutics market. A header for a Report: Personalized Medicine: A Game-Changer for the Intestine Cancer Therapeutics Market
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13231&type=smp
What Trends Will Shape the Intestine Cancer Therapeutics Market Through 2029 and Beyond?
In an effort to reach a wider audience, increase sales, and boost revenue, leading businesses within the intestine cancer therapeutics market are creating innovative products like Lonsurf. This drug, which is a mix of trifluridine and tipiracil, is used in the treatment of adult patients suffering from metastatic colorectal cancer. Taiho Oncology Inc., a pharmaceutical company based in the US, obtained approval for Lonsurf from the US Food and Drug Administration in August 2023. This drug is distributed as a single oral tablet. Trifluridine halts the proliferation of cancer cells and tipiracil aids in its functioning for a longer period by averting its breakdown by the body. The authorization of Lonsurf offers patients inflicted with metastatic colorectal cancer and other eligible types of cancer a novel treatment alternative that can potentially enhance their prognosis and quality of life.
What Are the Main Segments in the Intestine Cancer Therapeutics Market?
The intestine cancer therapeutics market covered in this report is segmented -
1) By Treatment Type: Immunotherapy, Chemotherapy, Other Treatments
2) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
3) By Application: Hospitals, Homecare, Specialty Centers, Other Applications
Subsegments:
1) By Immunotherapy: Checkpoint Inhibitors, CAR T-Cell Therapy, Cancer Vaccines
2) By Chemotherapy: Adjuvant Chemotherapy, Neoadjuvant Chemotherapy, Palliative Chemotherapy
3) By Other Treatments: Targeted Therapy, Radiation Therapy, Surgery, Hormone Therapy
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=13231&type=smp
Which Top Companies are Driving Growth in the Intestine Cancer Therapeutics Market?
Major companies operating in the intestine cancer therapeutics market report are Pfizer Inc., Johnson & Johnson Private Limited, Roche Holding AG, AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, Abbott Laboratories, GSK plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Merck KGaA, Mylan N.V., Astellas Pharma Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Boehringer Ingelheim International GmbH, Sun Pharmaceutical Industries Ltd., Ipsen Pharma, Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Cipla Inc., Aurobindo Pharma Limited, Lupin Limited
Which Regions Will Dominate the Intestine Cancer Therapeutics Market Through 2029?
Asia-Pacific was the largest region in the intestine cancer therapeutics market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the intestine cancer therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13231
"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Intestine Cancer Therapeutics Market Landscape 2025: Forecast Data and Growth Strategy Insights here
News-ID: 4124348 • Views: …
More Releases from The Business Research Company
Global Acrylic Powder Market Worth $77.43 Billion by 2029, Growing at 7.5% CAGR
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Acrylic Powder Market Outlook: What Size And CAGR Are Anticipated By 2025?
In recent years, the market size of acrylic powder has experienced significant growth. It is projected to expand from $54.48 billion in 2024 to $57.94 billion in 2025, with a compound annual growth rate (CAGR) of 6.4%. Factors…
Toluene Derivatives Industry to Achieve $8.45 Billion Growth by 2029
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
How Will the Toluene Derivatives Market Grow by 2025 in Terms of Size and Growth?
In recent times, the market size of toluene derivatives has considerably grown. The market is projected to rise from $5.98 billion in 2024 to $6.4 billion in 2025, with a compound annual growth rate (CAGR) of 7.0%.…
Sulfur Dioxide Market on Path to Hit $7.07 Billion by 2029 at 3.9% CAGR
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Sulfur Dioxide Market Outlook: What Size And CAGR Are Anticipated By 2025?
The sulfur dioxide market has seen a consistent growth in its size over the past few years. Projected to expand from $5.89 billion in 2024 to $6.08 billion in 2025, it is speculated to increase at a compound…
Release Agents Market to Surpass $1.35 Billion by 2029 | Key Trends & Insights
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
How Will the Release Agents Market Grow by 2025 in Terms of Size and Growth?
The market size of release agents has seen significant growth in recent years. The market is projected to expand from a value of $1.06 billion in 2024 to $1.11 billion in 2025, with a compound annual growth…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
